Siemens Healthineers and Novo partner to advance MASLD care

Siemens Healthineers and Novo announced a collaboration aimed at advancing care for people living with metabolic dysfunction-associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction-associated steatohepatitis (MASH).